01 Oct 2013, BioSpectrum Bureau , BioSpectrum
New Delhi: In a bid to move towards strict enforcement of the new drug pricing policy in India, the country's National Pharmaceutical Pricing Authority (NPPA) has said that pharma companies would get 15 days time to respond after the price revision notification is made.
The NPPA has said that it has been receiving representations from manufacturers seeking clarifications and corrections with regard to applicability of price notifications on their products as well as regarding omission and miscalculation errors.
The authority has warned that all the representation received after 15 days would be treated as ‘time barred' and would be rejected as ‘non-entertainable' without going into merits.
"As this exercise cannot be open ended, the authority has decided to fix a time limit. It has been decided that representations received within 15 days from the date of notification may be accepted and these will be dealt within 15 days of the receipt of the representations," NPPA has said.
NPPA has said that the ceiling prices of 338 scheduled medicines have been notified so far, of the 348 drugs that were included in the national list of essential medicines.